InvestorsHub Logo

biosectinvestor

06/12/20 2:07 AM

#289017 RE: Sankarad1 #289013

Agreed. if they want their own CFO, the partner, driving the affairs of the company, it would make sense that they keep it as an operating entity, and as a partner, that would be great in my book.

tryn2

06/12/20 6:28 AM

#289041 RE: Sankarad1 #289013

I’m not sure if LP would hand over the reins of this platform to anyone because of the fear that it might be bought out just to put it on the back shelf and continue with business as usual, so your statement has merit.

sentiment_stocks

06/12/20 9:35 PM

#289267 RE: Sankarad1 #289013

Or maybe Jean Davis was just moved into the area where she was most needed, and that the company had been cited for by the SEC, which were:

By 2018, the Company had remediated six of seven material weaknesses that had originally been identified, and the Company had two new weaknesses (relating to information technology policies and procedures, and documentation of the Company’s system of policies and procedures), as reported in the Company’s Form 10-K.
https://nwbio.com/nw-bio-moves-forward-sec-settlement/